Abstract
Mast cells (MCs) expressing a distinctive protease phenotype (MC T s) selectively expand within the epithelium of human mucosal tissues during type 2 (T2) inflammation. While MC T s are phenotypically distinct from subepithelial MCs (MC TC s), signals driving human MC T differentiation and this subset’s contribution to inflammation remain unexplored. Here, we have identified TGF-β as a key driver of the MC T transcriptome in nasal polyps. We found that short-term TGF-β signaling alters MC cell surface receptor expression and partially recapitulated the in vivo MC T transcriptome, while TGF-β signaling during MC differentiation upregulated a larger number of MC T -associated transcripts. TGF-β inhibited the hallmark MC TC proteases chymase and cathepsin G at both the transcript and protein level, allowing selective in vitro differentiation of MC T s for functional study. We identified discrete differences in effector phenotype between in vitro–derived MC T s and MC TC s, with MC T s exhibiting enhanced proinflammatory lipid mediator generation and a distinct cytokine, chemokine, and growth factor production profile in response to both innate and adaptive stimuli, recapitulating functional features of their tissue-associated counterpart MC subsets. Thus, our findings support a role for TGF-β in promoting human MC T differentiation and identified a discrete contribution of this cell type to T2 inflammation.
Funding Information
  • National Institutes of Health (AI078908,R37AI052353,R01AI136041,R01AI130109,R01AI175149,U19 AI095219,K22 AI146281)
  • Brigham and Women's Hospital (Hearst Young Investigator Award)

This publication has 65 references indexed in Scilit: